Evidence record 19250 · automatically gathered

Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis

Background: Non–small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Accurate early prediction of response to neoadjuvant therapy is critical. Objective: We aimed to evaluate the diagnostic performance of radiomics-based AI in predicting pathological complete response (pCR) and major pathological response (MPR) following neoadjuvant immunochemotherapy in NSCLC and to compare it against traditional radiological criteria. Methods: A systematic search of P

Record details

Published: 14 August 2026
Source: JMIR (Journal of Medical Internet Research)
Category: Research
Topics: Healthcare
Retrieved: 14 August 2026

source-onlyevidence status

These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.

How to cite this record

ethics.ai (14 August 2026), “Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis,” evidence record 19250, https://ethics.ai/record/19250 (originally published by JMIR (Journal of Medical Internet Research)).

JSON

Use and limitations

This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.